Loading…

Surface functionalization of zeolite-based drug delivery systems enhances their antitumoral activity in vivo

Zeolites have attractive features making them suitable carriers for drug delivery systems (DDS). As such, we loaded the anticancer drug 5-fluorouracil (5-FU), into two different zeolite structures, faujasite (NaY) and Linde Type L (LTL), to obtain different DDS. The prepared DDS were tested in vitro...

Full description

Saved in:
Bibliographic Details
Published in:Materials Science & Engineering C 2021-01, Vol.120, p.111721, Article 111721
Main Authors: Vilaça, Natália, Bertão, Ana Raquel, Prasetyanto, Eko Adi, Granja, Sara, Costa, Marta, Fernandes, Rui, Figueiredo, Francisco, Fonseca, António M., De Cola, Luisa, Baltazar, Fátima, Neves, Isabel C.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c453t-f5c4a6fd8384b499f24506aa4ca63333e7729a361febdc6ed0c6c3f8f8fda98f3
cites cdi_FETCH-LOGICAL-c453t-f5c4a6fd8384b499f24506aa4ca63333e7729a361febdc6ed0c6c3f8f8fda98f3
container_end_page
container_issue
container_start_page 111721
container_title Materials Science & Engineering C
container_volume 120
creator Vilaça, Natália
Bertão, Ana Raquel
Prasetyanto, Eko Adi
Granja, Sara
Costa, Marta
Fernandes, Rui
Figueiredo, Francisco
Fonseca, António M.
De Cola, Luisa
Baltazar, Fátima
Neves, Isabel C.
description Zeolites have attractive features making them suitable carriers for drug delivery systems (DDS). As such, we loaded the anticancer drug 5-fluorouracil (5-FU), into two different zeolite structures, faujasite (NaY) and Linde Type L (LTL), to obtain different DDS. The prepared DDS were tested in vitro using breast cancer, colorectal carcinoma, and melanoma cell lines and in vivo using the chick embryo chorioallantoic membrane model (CAM). Both assays showed the best results for the Hs578T breast cancer cells, with a higher potentiation for 5-FU encapsulated in the zeolite LTL. To unveil the endocytic mechanisms involved in the internalization of the zeolite nanoparticles, endocytosis was inhibited pharmacologically in breast cancer and epithelial mammary human cells. The results suggest that a caveolin-mediated process was responsible for the internalized zeolite nanoparticles. Aiming to boost the DDS efficacy, the disc-shaped zeolite LTL outer surface was functionalized using amino (NH2) or carboxylic acid (COOH) groups and coated with poly-l-lysine (PLL). Positively functionalized surface LTL nanoparticles revealed to be non-toxic to human cells and, importantly, their internalization was faster and led to a higher tumor reduction in vivo. Overall, our results provide further insights into the mechanisms of interaction between zeolite-based DDS and cancer cells, and pave the way for future studies aiming to improve DDS anticancer activity. [Display omitted] •5-FU DDS-based zeolite nanoparticles exhibit good anticancer efficacy in vitro and in vivo.•Zeolite nanoparticles are mainly internalized by a caveolin-mediated process in cancer cells.•NH2 DDS functionalization increases their antitumoral activity in vivo.
doi_str_mv 10.1016/j.msec.2020.111721
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2497224594</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0928493120336407</els_id><sourcerecordid>2497224594</sourcerecordid><originalsourceid>FETCH-LOGICAL-c453t-f5c4a6fd8384b499f24506aa4ca63333e7729a361febdc6ed0c6c3f8f8fda98f3</originalsourceid><addsrcrecordid>eNp9kE1rGzEQhkVJqJ20f6CHIuh5HX3th6CXYvIFgRySnIUsjRqZ3ZUraRecXx8ZOz1Gc9AwvPPAPAj9oGRFCW2utqshgVkxwsqA0pbRL2hJu5ZXhEp6hpZEsq4SktMFukhpS0jT8ZZ9RQvOa1F3LVui_mmKThvAbhpN9mHUvX_ThwYHh98g9D5DtdEJLLZx-ost9H6GuMdpnzIMCcP4qkcDCedX8BHrMfs8DSHqHutCnH3eYz_i2c_hGzp3uk_w_fRfopeb6-f1XfXweHu__vNQGVHzXLnaCN042_FObISUjomaNFoLoxteHrQtk5o31MHGmgYsMY3hritltewcv0S_jtxdDP8mSFltwxTLaUkxIVtWeFKUFDumTAwpRXBqF_2g415Rog6C1VYdBKuDYHUUXJZ-ntDTZgD7f-XDaAn8PgagHDh7iCoZD0WQ9RFMVjb4z_jvmIOPCA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2497224594</pqid></control><display><type>article</type><title>Surface functionalization of zeolite-based drug delivery systems enhances their antitumoral activity in vivo</title><source>ScienceDirect Journals</source><creator>Vilaça, Natália ; Bertão, Ana Raquel ; Prasetyanto, Eko Adi ; Granja, Sara ; Costa, Marta ; Fernandes, Rui ; Figueiredo, Francisco ; Fonseca, António M. ; De Cola, Luisa ; Baltazar, Fátima ; Neves, Isabel C.</creator><creatorcontrib>Vilaça, Natália ; Bertão, Ana Raquel ; Prasetyanto, Eko Adi ; Granja, Sara ; Costa, Marta ; Fernandes, Rui ; Figueiredo, Francisco ; Fonseca, António M. ; De Cola, Luisa ; Baltazar, Fátima ; Neves, Isabel C.</creatorcontrib><description>Zeolites have attractive features making them suitable carriers for drug delivery systems (DDS). As such, we loaded the anticancer drug 5-fluorouracil (5-FU), into two different zeolite structures, faujasite (NaY) and Linde Type L (LTL), to obtain different DDS. The prepared DDS were tested in vitro using breast cancer, colorectal carcinoma, and melanoma cell lines and in vivo using the chick embryo chorioallantoic membrane model (CAM). Both assays showed the best results for the Hs578T breast cancer cells, with a higher potentiation for 5-FU encapsulated in the zeolite LTL. To unveil the endocytic mechanisms involved in the internalization of the zeolite nanoparticles, endocytosis was inhibited pharmacologically in breast cancer and epithelial mammary human cells. The results suggest that a caveolin-mediated process was responsible for the internalized zeolite nanoparticles. Aiming to boost the DDS efficacy, the disc-shaped zeolite LTL outer surface was functionalized using amino (NH2) or carboxylic acid (COOH) groups and coated with poly-l-lysine (PLL). Positively functionalized surface LTL nanoparticles revealed to be non-toxic to human cells and, importantly, their internalization was faster and led to a higher tumor reduction in vivo. Overall, our results provide further insights into the mechanisms of interaction between zeolite-based DDS and cancer cells, and pave the way for future studies aiming to improve DDS anticancer activity. [Display omitted] •5-FU DDS-based zeolite nanoparticles exhibit good anticancer efficacy in vitro and in vivo.•Zeolite nanoparticles are mainly internalized by a caveolin-mediated process in cancer cells.•NH2 DDS functionalization increases their antitumoral activity in vivo.</description><identifier>ISSN: 0928-4931</identifier><identifier>EISSN: 1873-0191</identifier><identifier>DOI: 10.1016/j.msec.2020.111721</identifier><identifier>PMID: 33545872</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>5-Fluorouracil ; Animals ; Anticancer properties ; Antineoplastic Agents - pharmacology ; Antitumor activity ; Biocompatibility ; Breast cancer ; Cancer models ; Carboxylic acids ; Caveolin ; Chick Chorioallantoic membrane (CAM) assay ; Chick Embryo ; Chorioallantoic membrane ; Colorectal carcinoma ; Drug Carriers ; Drug delivery ; Drug Delivery Systems ; Drug delivery systems (DDS) ; Embryos ; Endocytosis ; Fluorouracil - pharmacology ; Humans ; Internalization ; Lysine ; Materials science ; Melanoma ; Nanoparticles ; Poly-L-lysine ; Surface functionalization ; Tumor cell lines ; Zeolite nanoparticles ; Zeolites ; Zeolites - pharmacology</subject><ispartof>Materials Science &amp; Engineering C, 2021-01, Vol.120, p.111721, Article 111721</ispartof><rights>2020 Elsevier B.V.</rights><rights>Copyright © 2020 Elsevier B.V. All rights reserved.</rights><rights>Copyright Elsevier BV Jan 2021</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c453t-f5c4a6fd8384b499f24506aa4ca63333e7729a361febdc6ed0c6c3f8f8fda98f3</citedby><cites>FETCH-LOGICAL-c453t-f5c4a6fd8384b499f24506aa4ca63333e7729a361febdc6ed0c6c3f8f8fda98f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33545872$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vilaça, Natália</creatorcontrib><creatorcontrib>Bertão, Ana Raquel</creatorcontrib><creatorcontrib>Prasetyanto, Eko Adi</creatorcontrib><creatorcontrib>Granja, Sara</creatorcontrib><creatorcontrib>Costa, Marta</creatorcontrib><creatorcontrib>Fernandes, Rui</creatorcontrib><creatorcontrib>Figueiredo, Francisco</creatorcontrib><creatorcontrib>Fonseca, António M.</creatorcontrib><creatorcontrib>De Cola, Luisa</creatorcontrib><creatorcontrib>Baltazar, Fátima</creatorcontrib><creatorcontrib>Neves, Isabel C.</creatorcontrib><title>Surface functionalization of zeolite-based drug delivery systems enhances their antitumoral activity in vivo</title><title>Materials Science &amp; Engineering C</title><addtitle>Mater Sci Eng C Mater Biol Appl</addtitle><description>Zeolites have attractive features making them suitable carriers for drug delivery systems (DDS). As such, we loaded the anticancer drug 5-fluorouracil (5-FU), into two different zeolite structures, faujasite (NaY) and Linde Type L (LTL), to obtain different DDS. The prepared DDS were tested in vitro using breast cancer, colorectal carcinoma, and melanoma cell lines and in vivo using the chick embryo chorioallantoic membrane model (CAM). Both assays showed the best results for the Hs578T breast cancer cells, with a higher potentiation for 5-FU encapsulated in the zeolite LTL. To unveil the endocytic mechanisms involved in the internalization of the zeolite nanoparticles, endocytosis was inhibited pharmacologically in breast cancer and epithelial mammary human cells. The results suggest that a caveolin-mediated process was responsible for the internalized zeolite nanoparticles. Aiming to boost the DDS efficacy, the disc-shaped zeolite LTL outer surface was functionalized using amino (NH2) or carboxylic acid (COOH) groups and coated with poly-l-lysine (PLL). Positively functionalized surface LTL nanoparticles revealed to be non-toxic to human cells and, importantly, their internalization was faster and led to a higher tumor reduction in vivo. Overall, our results provide further insights into the mechanisms of interaction between zeolite-based DDS and cancer cells, and pave the way for future studies aiming to improve DDS anticancer activity. [Display omitted] •5-FU DDS-based zeolite nanoparticles exhibit good anticancer efficacy in vitro and in vivo.•Zeolite nanoparticles are mainly internalized by a caveolin-mediated process in cancer cells.•NH2 DDS functionalization increases their antitumoral activity in vivo.</description><subject>5-Fluorouracil</subject><subject>Animals</subject><subject>Anticancer properties</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Antitumor activity</subject><subject>Biocompatibility</subject><subject>Breast cancer</subject><subject>Cancer models</subject><subject>Carboxylic acids</subject><subject>Caveolin</subject><subject>Chick Chorioallantoic membrane (CAM) assay</subject><subject>Chick Embryo</subject><subject>Chorioallantoic membrane</subject><subject>Colorectal carcinoma</subject><subject>Drug Carriers</subject><subject>Drug delivery</subject><subject>Drug Delivery Systems</subject><subject>Drug delivery systems (DDS)</subject><subject>Embryos</subject><subject>Endocytosis</subject><subject>Fluorouracil - pharmacology</subject><subject>Humans</subject><subject>Internalization</subject><subject>Lysine</subject><subject>Materials science</subject><subject>Melanoma</subject><subject>Nanoparticles</subject><subject>Poly-L-lysine</subject><subject>Surface functionalization</subject><subject>Tumor cell lines</subject><subject>Zeolite nanoparticles</subject><subject>Zeolites</subject><subject>Zeolites - pharmacology</subject><issn>0928-4931</issn><issn>1873-0191</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kE1rGzEQhkVJqJ20f6CHIuh5HX3th6CXYvIFgRySnIUsjRqZ3ZUraRecXx8ZOz1Gc9AwvPPAPAj9oGRFCW2utqshgVkxwsqA0pbRL2hJu5ZXhEp6hpZEsq4SktMFukhpS0jT8ZZ9RQvOa1F3LVui_mmKThvAbhpN9mHUvX_ThwYHh98g9D5DtdEJLLZx-ost9H6GuMdpnzIMCcP4qkcDCedX8BHrMfs8DSHqHutCnH3eYz_i2c_hGzp3uk_w_fRfopeb6-f1XfXweHu__vNQGVHzXLnaCN042_FObISUjomaNFoLoxteHrQtk5o31MHGmgYsMY3hritltewcv0S_jtxdDP8mSFltwxTLaUkxIVtWeFKUFDumTAwpRXBqF_2g415Rog6C1VYdBKuDYHUUXJZ-ntDTZgD7f-XDaAn8PgagHDh7iCoZD0WQ9RFMVjb4z_jvmIOPCA</recordid><startdate>202101</startdate><enddate>202101</enddate><creator>Vilaça, Natália</creator><creator>Bertão, Ana Raquel</creator><creator>Prasetyanto, Eko Adi</creator><creator>Granja, Sara</creator><creator>Costa, Marta</creator><creator>Fernandes, Rui</creator><creator>Figueiredo, Francisco</creator><creator>Fonseca, António M.</creator><creator>De Cola, Luisa</creator><creator>Baltazar, Fátima</creator><creator>Neves, Isabel C.</creator><general>Elsevier B.V</general><general>Elsevier BV</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QF</scope><scope>7QO</scope><scope>7QQ</scope><scope>7SC</scope><scope>7SE</scope><scope>7SP</scope><scope>7SR</scope><scope>7T7</scope><scope>7TA</scope><scope>7TB</scope><scope>7U5</scope><scope>8BQ</scope><scope>8FD</scope><scope>C1K</scope><scope>F28</scope><scope>FR3</scope><scope>H8D</scope><scope>H8G</scope><scope>JG9</scope><scope>JQ2</scope><scope>KR7</scope><scope>L7M</scope><scope>L~C</scope><scope>L~D</scope><scope>P64</scope></search><sort><creationdate>202101</creationdate><title>Surface functionalization of zeolite-based drug delivery systems enhances their antitumoral activity in vivo</title><author>Vilaça, Natália ; Bertão, Ana Raquel ; Prasetyanto, Eko Adi ; Granja, Sara ; Costa, Marta ; Fernandes, Rui ; Figueiredo, Francisco ; Fonseca, António M. ; De Cola, Luisa ; Baltazar, Fátima ; Neves, Isabel C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c453t-f5c4a6fd8384b499f24506aa4ca63333e7729a361febdc6ed0c6c3f8f8fda98f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>5-Fluorouracil</topic><topic>Animals</topic><topic>Anticancer properties</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Antitumor activity</topic><topic>Biocompatibility</topic><topic>Breast cancer</topic><topic>Cancer models</topic><topic>Carboxylic acids</topic><topic>Caveolin</topic><topic>Chick Chorioallantoic membrane (CAM) assay</topic><topic>Chick Embryo</topic><topic>Chorioallantoic membrane</topic><topic>Colorectal carcinoma</topic><topic>Drug Carriers</topic><topic>Drug delivery</topic><topic>Drug Delivery Systems</topic><topic>Drug delivery systems (DDS)</topic><topic>Embryos</topic><topic>Endocytosis</topic><topic>Fluorouracil - pharmacology</topic><topic>Humans</topic><topic>Internalization</topic><topic>Lysine</topic><topic>Materials science</topic><topic>Melanoma</topic><topic>Nanoparticles</topic><topic>Poly-L-lysine</topic><topic>Surface functionalization</topic><topic>Tumor cell lines</topic><topic>Zeolite nanoparticles</topic><topic>Zeolites</topic><topic>Zeolites - pharmacology</topic><toplevel>online_resources</toplevel><creatorcontrib>Vilaça, Natália</creatorcontrib><creatorcontrib>Bertão, Ana Raquel</creatorcontrib><creatorcontrib>Prasetyanto, Eko Adi</creatorcontrib><creatorcontrib>Granja, Sara</creatorcontrib><creatorcontrib>Costa, Marta</creatorcontrib><creatorcontrib>Fernandes, Rui</creatorcontrib><creatorcontrib>Figueiredo, Francisco</creatorcontrib><creatorcontrib>Fonseca, António M.</creatorcontrib><creatorcontrib>De Cola, Luisa</creatorcontrib><creatorcontrib>Baltazar, Fátima</creatorcontrib><creatorcontrib>Neves, Isabel C.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Aluminium Industry Abstracts</collection><collection>Biotechnology Research Abstracts</collection><collection>Ceramic Abstracts</collection><collection>Computer and Information Systems Abstracts</collection><collection>Corrosion Abstracts</collection><collection>Electronics &amp; Communications Abstracts</collection><collection>Engineered Materials Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Materials Business File</collection><collection>Mechanical &amp; Transportation Engineering Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ANTE: Abstracts in New Technology &amp; Engineering</collection><collection>Engineering Research Database</collection><collection>Aerospace Database</collection><collection>Copper Technical Reference Library</collection><collection>Materials Research Database</collection><collection>ProQuest Computer Science Collection</collection><collection>Civil Engineering Abstracts</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>Computer and Information Systems Abstracts – Academic</collection><collection>Computer and Information Systems Abstracts Professional</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Materials Science &amp; Engineering C</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vilaça, Natália</au><au>Bertão, Ana Raquel</au><au>Prasetyanto, Eko Adi</au><au>Granja, Sara</au><au>Costa, Marta</au><au>Fernandes, Rui</au><au>Figueiredo, Francisco</au><au>Fonseca, António M.</au><au>De Cola, Luisa</au><au>Baltazar, Fátima</au><au>Neves, Isabel C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Surface functionalization of zeolite-based drug delivery systems enhances their antitumoral activity in vivo</atitle><jtitle>Materials Science &amp; Engineering C</jtitle><addtitle>Mater Sci Eng C Mater Biol Appl</addtitle><date>2021-01</date><risdate>2021</risdate><volume>120</volume><spage>111721</spage><pages>111721-</pages><artnum>111721</artnum><issn>0928-4931</issn><eissn>1873-0191</eissn><abstract>Zeolites have attractive features making them suitable carriers for drug delivery systems (DDS). As such, we loaded the anticancer drug 5-fluorouracil (5-FU), into two different zeolite structures, faujasite (NaY) and Linde Type L (LTL), to obtain different DDS. The prepared DDS were tested in vitro using breast cancer, colorectal carcinoma, and melanoma cell lines and in vivo using the chick embryo chorioallantoic membrane model (CAM). Both assays showed the best results for the Hs578T breast cancer cells, with a higher potentiation for 5-FU encapsulated in the zeolite LTL. To unveil the endocytic mechanisms involved in the internalization of the zeolite nanoparticles, endocytosis was inhibited pharmacologically in breast cancer and epithelial mammary human cells. The results suggest that a caveolin-mediated process was responsible for the internalized zeolite nanoparticles. Aiming to boost the DDS efficacy, the disc-shaped zeolite LTL outer surface was functionalized using amino (NH2) or carboxylic acid (COOH) groups and coated with poly-l-lysine (PLL). Positively functionalized surface LTL nanoparticles revealed to be non-toxic to human cells and, importantly, their internalization was faster and led to a higher tumor reduction in vivo. Overall, our results provide further insights into the mechanisms of interaction between zeolite-based DDS and cancer cells, and pave the way for future studies aiming to improve DDS anticancer activity. [Display omitted] •5-FU DDS-based zeolite nanoparticles exhibit good anticancer efficacy in vitro and in vivo.•Zeolite nanoparticles are mainly internalized by a caveolin-mediated process in cancer cells.•NH2 DDS functionalization increases their antitumoral activity in vivo.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>33545872</pmid><doi>10.1016/j.msec.2020.111721</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0928-4931
ispartof Materials Science & Engineering C, 2021-01, Vol.120, p.111721, Article 111721
issn 0928-4931
1873-0191
language eng
recordid cdi_proquest_journals_2497224594
source ScienceDirect Journals
subjects 5-Fluorouracil
Animals
Anticancer properties
Antineoplastic Agents - pharmacology
Antitumor activity
Biocompatibility
Breast cancer
Cancer models
Carboxylic acids
Caveolin
Chick Chorioallantoic membrane (CAM) assay
Chick Embryo
Chorioallantoic membrane
Colorectal carcinoma
Drug Carriers
Drug delivery
Drug Delivery Systems
Drug delivery systems (DDS)
Embryos
Endocytosis
Fluorouracil - pharmacology
Humans
Internalization
Lysine
Materials science
Melanoma
Nanoparticles
Poly-L-lysine
Surface functionalization
Tumor cell lines
Zeolite nanoparticles
Zeolites
Zeolites - pharmacology
title Surface functionalization of zeolite-based drug delivery systems enhances their antitumoral activity in vivo
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T12%3A26%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Surface%20functionalization%20of%20zeolite-based%20drug%20delivery%20systems%20enhances%20their%20antitumoral%20activity%20in%20vivo&rft.jtitle=Materials%20Science%20&%20Engineering%20C&rft.au=Vila%C3%A7a,%20Nat%C3%A1lia&rft.date=2021-01&rft.volume=120&rft.spage=111721&rft.pages=111721-&rft.artnum=111721&rft.issn=0928-4931&rft.eissn=1873-0191&rft_id=info:doi/10.1016/j.msec.2020.111721&rft_dat=%3Cproquest_cross%3E2497224594%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c453t-f5c4a6fd8384b499f24506aa4ca63333e7729a361febdc6ed0c6c3f8f8fda98f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2497224594&rft_id=info:pmid/33545872&rfr_iscdi=true